In summary, LncRNA-SERB could promote ccRCC VM formation and invasion via altering the LncRNA-SER/ERβ/ZEB1 signals and targeting these newly identified signals may help physicians to develop a new therapy to better suppress the ccRCC progression. This evidence concerns the gene ESR2 and nonpapillary renal cell carcinoma.